Introduction {#S1}
============

Bisphenol A (BPA) is an organic synthetic compound widely used to make polycarbonate plastics and epoxy resins utilized in reusable food and drink containers and inner lining of cans and bottles ([@B1]). Hydrolysis of the ester-bond linking BPA can occur at high temperature, and BPA can be leached out into food and beverages. Fetuses or young animals during their developmental stages are thought to be susceptible to BPA exposure than adults ([@B2]). Therefore, detectable level of BPA in 88% of human cord blood samples ([@B3]) generated social concerns about the effect of BPA on the fetuses.

Dodds and Lawson were the first to show the estrogenic property of BPA ([@B4]). However, the estrogenic effect of BPA is 10,000 times less potent than estradiol-17β shown by uterine vascular permeability assay in ovariectomized mice ([@B5]). Similar level of agonistic activity of BPA to estrogen receptor (ER) was shown in yeast expressing human estrogen or androgen receptor (AR) ([@B6]). On the other hand, BPA is a potent ligand for the non-classic membrane bound G protein-coupled receptor for estrogen (GPR30) ([@B7], [@B8]). BPA did not have an agonistic activity but had an antagonistic activity to AR in the same yeast-based assay ([@B6]). Stronger antagonistic activity of BPA to human AR was shown in an African monkey kidney cell line ([@B9]). It is also known that BPA can disturb steroidogenesis by interfering the activity of steroidogenic enzymes, such as CYP450scc, 3βHSD, and CYP450arom ([@B10]). Perera et al. ([@B11]) examined the association between prenatal BPA exposure and child behavior. They found that high prenatal BPA exposure was associated with higher emotionally reactive and aggressive behavior syndromes in boys and lower anxious/depressed and aggressive behavior in girls ([@B11]). There are numerous studies showing the effect of perinatally administered BPA on social behavior of rodents. BPA exposure during pregnancy increased display of nose-to-nose contacts, play solicitations, and approaches in both sexes ([@B12]). Administration of BPA during pregnancy or lactation increased defensive behavior in male and sexual behavior in female rats ([@B13]). In the other study, BPA exposed males during gestation and lactation showed persistent deficits in sexual behavior in adulthood ([@B14]).

To find BPA responsive genes in the brain mediating its effect on social behavior, we first focused on amygdala, because amygdala is the integrative center for the processing of emotion, which is pivotal for social behavior. It is thought that deficits in the development of amygdala may cause autism, a neurodevelopmental disorder that is characterized by impaired social interaction (the amygdala theory of autism) ([@B15]). It is also known that these brain nuclei express ARs and ERs and abnormally enlarge in autism infants ([@B16]). We subcutaneously administered a reference dose of BPA (50 µg/kg BW/day) determined by United States Environmental Protection Agency (EPA, [www.epa.gov/iris/subst/0356.htm](www.epa.gov/iris/subst/0356.htm)) to neonatal male transgenic rats carrying enhanced green fluorescent protein tagged to gonadotropin-inhibitory hormone \[EGFP-GnIH ([@B17])\] promoter from day 1 to 3 and differential expressions of AR and ER signaling target genes in the medial amygdala were analyzed by polymerase chain reaction (PCR) array. GnIH is a hypothalamic neuropeptide that decreases gonadotropin secretion directly acting on the pituitary or by decreasing the activity of gonadotropin-releasing hormone (GnRH) neurons ([@B18], [@B19]). Recent studies have shown that GnIH neurons also decrease motivated behavior ([@B20], [@B21]). We found upregulation of transmembrane protease serine 2 (*Tmprss2*) and downregulation of Forkhead box A1 (*Foxa1*) mRNAs in the amygdala by BPA exposure. We further studied the location of Tmprss2 and Foxa1 immunoreactive (ir) cells, effect of BPA on the density of Tmprss2 and Foxa1-ir cells and developmental changes in *Tmprss2* and *Foxa1* mRNA expressions in the male rat brain.

Materials and Methods {#S2}
=====================

Animals {#S2-1}
-------

EGFP-GnIH Wistar rats ([@B17]) were housed under a controlled 12 h light/dark cycle (light on at noon) and the temperature was maintained at 22°C in a specific pathogen free animal facility. All rats had free access to autoclaved food and water. The pups were counted after parturition, weighed, and remained with their biological mother. All procedures were approved by Monash University, Animal Ethics Committee (MARP/2016/037).

PCR Array {#S2-2}
---------

Bisphenol A at 50 µg/kg or vehicle (sesame oil) was subcutaneously injected to neonatal male rats after dawn daily from postnatal day 1 (P1) to P3. 2 h after the last injection the rats were deeply anesthetized by Zoletil/Ketamine/Xylazine (Z/K/X) at 13.5 mg/90 μl/kg and brains were collected and stored at −80°C. Medial amygdaloid tissue from both sides of the brain was dissected in a cryostat at −20°C by referring to a rat brain atlas ([@B22]). Medial amygdaloid tissues from two male siblings were combined in a tube for homogenization. Total medial amygdaloid tissue samples of six BPA treated rats from three different littermates and six vehicle treated rats from three different littermates were collected. Total RNA was extracted by using an RNA isolation kit (RNeasy mini kit; QIAGEN, Hilden, Germany) and reverse transcribed by using High-Capacity cDNA Reverse Transcription Kit (ThermoFisher SCIENTIFIC, Waltham, MA, USA). Differential gene expression was analyzed by PCR arrays, RT^2^ Profiler™ PCR Array Rat AR Signaling Targets, and RT^2^ Profiler™ PCR Array Rat ER Signaling Targets (QIAGEN). These PCR array kits analyze the expression levels of 84 AR signaling target genes (Table S1 in Supplementary Material) and 84 ER signaling target genes (Table S2 in Supplementary Material). Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2, NM_053698), insulin-like growth factor binding protein 5 (Igfbp5, NM_012817), kallikrein B plasma 1 (Klkb1, NM_012725), and myelocytomatosis oncogene (Myc, NM_012603) were analyzed in both assays. Real-time PCR was performed using a StepOnePlus™ Real-Time PCR System (ThermoFisher SCIENTIFIC) with conditions of 95°C for 10 min, 40 cycles of 95°C for 15 s, and 60°C for 1 min, followed by a dissociation step according to the manufacturer's instruction. Expression levels of AR signaling target genes were normalized by the mean expression levels of housekeeping genes (HKGs), actin beta (Actb, NM_031144), Hypoxanthine phosphoribosyltransferase 1 (Hprt1, NM_012583), lactate dehydrogenase A (Ldha, NM_017025), and ribosomal protein large P1 (Rplp1, NM_001007604) using the ΔΔCt method. Expression levels of ER signaling target genes were normalized by the mean expression levels of Hprt1 and Rplp1, which were selected from the HKGs by the software based on their consistent expression levels within all samples. Ct cut-off was set to 35 in both assays and treated as undetectable.

Real-Time PCR {#S2-3}
-------------

Five P3 male brains and five P35 male brains were collected under deep anesthesia by Z/K/X at 13.5 mg/90 μl/kg and stored at −80°C. Amygdala, hypothalamus, and telencephalon excluding amygdala and hippocampus were collected in a cryostat at −20°C. Tissues were homogenized in TRIzol™ Reagent (ThermoFisher SCIENTIFIC) and total RNA was extracted by chloroform. Total RNA was reverse transcribed by using High-Capacity cDNA Reverse Transcription Kit (ThermoFisher SCIENTIFIC). Expression levels of *Rattus norvegicus* Tmprss2 mRNA (NM_130424.3) and Foxa1 mRNA (NM_012742.1) were measured using Rplp1 mRNA (NM_001007604.2) as a reference HKG. Real-time PCR was performed using SensiFAST SYBR Master Mix (BioLine Reagent, London, United Kingdom) and primers (Tmprss2 forward: 5′-CACCTGCCATCCACATACAG-3′, reverse: 5′-CCAGAACTTCCAAAGCAAGC-3′; Foxa1 forward: 5′-GGAGGCCTACTCCTCTGTCC-3′, reverse: 5′-TTGGCGTAGGACATGTTGAA-3′; Rplp1 forward: 5′-GACGGTCACGGAGGATAAGA-3′, reverse: 5′-GCAGATGAGGCTTCCAATGT-3′). Real-time PCR was performed using a StepOnePlus™ Real-Time PCR System (ThermoFisher SCIENTIFIC) with conditions of 95°C for 2 min, 40 cycles of 95°C for 5 s, and 60°C for 30 s, followed by a dissociation step. The levels of each mRNA were normalized to Rplp1 mRNA using the ΔΔCt method.

Immunohistochemistry and Fluorescent Microscopy {#S2-4}
-----------------------------------------------

Immunohistochemistry was performed to investigate the location of Tmprss2 and Foxa1 protein in P3 male rat brains using rabbit monoclonal anti-TMPRSS2 antibody (EPR3861; abcam, Cambridge, United Kingdom) and anti-FOXA1 antibody (EPR10881: abcam). Briefly, five P3 male rats' brains were collected in 4% paraformaldehyde (PFA) under deep anesthetized by Z/K/X at 13.5 mg/90 μl/kg. After 5 days in 4% PFA at 4°C, brains were soaked in 30% sucrose in 0.1 M phosphate buffer at 4°C until they sank. Brains were kept at −80°C until sectioning at 20 µm thickness on a cryostat at −20°C. Sections were incubated in 0.3% H~2~O~2~ in 20% methanol in 0.01 M phosphate buffered saline (PBS; pH 7.0) for 20 min to suppress endogenous peroxidase activity. Sections were then washed three times in PBS and incubated overnight at 4°C in the primary antibody at concentrations of 1:300 for anti-TMPRSS2 antibody and 1:200 for anti-FOXA1 antibody in blocking solution (0.5% Triton X, 2% normal goat serum in PBS). The next day, three subsequent washes in PBS were followed by incubation in biotinylated goat anti-rabbit IgG at 1:500 in blocking solution for 40 min. After the sections were washed in PBS three times, they were then incubated for 45 min in avidin--biotin complex (Vectastain Elite Kit, Vector, Burlingame, CA, USA) in blocking solution. The resulting complex was visualized by 3,3-diaminobenzidine after the sections were washed three times in PBS and rinsed in 0.05 M Tris--HCl buffer (pH 7.5). Immunohistochemistry without the primary antibodies served as control. The location of the immunoreactivities was identified by Nissl staining of the adjacent sections.

Number of Tmprss2-ir cells in the medial amygdala was counted in three 100 µm grids and averaged for each P3 male rat that were subcutaneously injected with BPA at 50 μg/kg/day (*n* = 5) or vehicle (*n* = 4) from P1 to P3. Number of Foxa1-ir cells in the hypothalamus was counted in three 100 µm grids and averaged for each P3 male rat that were subcutaneously injected with BPA at 50 μg/kg/day (*n* = 4) or vehicle (*n* = 4) from P1 to P3.

Co-localization of Tmprss2 or Foxa1 immunoreactivity and GnIH-EGFP was studied using a fluorescent microscope with bright field function. The secondary antibody (biotinylated goat anti-rabbit IgG) for immunohistochemistry was used at 1:200 to investigate the co-localization of Tmprss2 or Foxa1 and GnIH-EGFP.

Statistics {#S2-5}
----------

Differential expression of AR and ER signaling target genes in the medial amygdala, number of Tmprss2-ir cells in the medial amygdala, and number of Foxa1-ir cells in the hypothalamus between BPA administered male rats and control rats were analyzed by Student's *t*-test. Differential expression of Tmprss2 and Foxa1 in the amygdala, hypothalamus, and telencephalon excluding amygdala and hippocampus in P3 and P35 male rat brains was analyzed by one-way ANOVA followed by Fisher's protected least significant difference test.

Results {#S3}
=======

Effect of BPA on AR and ER Signaling Target Gene Expression in the Medial Amygdala of Neonatal Male Rats {#S3-1}
--------------------------------------------------------------------------------------------------------

Differential expression of AR and ER signaling target genes in the medial amygdala by BPA administration was analyzed in neonatal male rats. Klkb1 (NM_012725), orosomucoid 1 (Orm1, NM_053288), and progastricsin (pepsinogen C) (Pgc, NM_133284) were undetectable within the 84 AR signaling target genes, and cytochrome P450 family 1 subfamily a polypeptide 1 (Cyp1a1, NM_012540), Klkb1 (NM_012725), nuclear receptor subfamily 0 group B member 2 (Nr0b2, NM_057133) were undetectable within the 84 ER signaling target genes (Table [1](#T1){ref-type="table"}). Genes analyzed in both assays (Cited2, Igfbp5, Klkb1, Myc) produced similar results in terms of detectability, fold changes by BPA treatment, and *P* values by Student's *t*-test (Table [1](#T1){ref-type="table"}).

###### 

Effect of Bisphenol A (BPA) on androgen receptor (AR) and estrogen receptor (ER) signaling target gene expression in the medial amygdala of neonatal male rats.

  AR signaling target genes   ER signaling target genes                                                               
  --------------------------- --------------------------- ---------------------------------------- ---------- ------- ----------------------------------------
  Abcc4                       1.10                        0.627                                    Adora1     1.09    0.735
  Abhd2                       1.12                        0.508                                    Ahr        1.11    0.837
  Acsl3                       0.99                        0.913                                    Akap1      1.23    0.424
  Adamts1                     0.91                        0.751                                    Apbb1      1.11    0.665
  Aldh1a3                     0.89                        0.646                                    Bcar1      1.13    0.634
  Appbp2                      0.99                        0.944                                    Bcl2l1     1.08    0.634
  Ar                          0.95                        0.434                                    Bdnf       1.07    0.810
  Atad2                       1.13                        0.655                                    Bmp4       0.89    0.673
  Camkk2                      1.14                        0.191                                    Bmp7       6.46    0.585
  Cenpn                       0.98                        0.948                                    Brca1      0.62    0.0541
  Cited2                      1.11                        0.696                                    C3         1.00    0.925
  Ackr3                       1.01                        0.929                                    Cav1       1.06    0.719
  Cyp2u1                      1.00                        0.897                                    Ccl12      0.87    0.916
  Dhcr24                      1.21                        0.387                                    Ccnd1      0.98    0.944
  Eaf2                        0.56                        0.0645                                   Cited2     1.26    0.526
  Elk1                        1.14                        0.391                                    Ckb        0.97    0.853
  Ell2                        1.01                        0.935                                    Ctgf       0.76    0.359
  Ern1                        1.21                        0.392                                    Ctsd       1.06    0.899
  Errfi1                      1.16                        0.564                                    Cyp19a1    1.01    0.975
  Fam105a                     0.99                        0.832                                    Cyp1a1     --      --
  Fkbp5                       1.08                        0.571                                    Ebag9      15.05   0.266
  Fos                         0.80                        0.252                                    Efna5      1.27    0.257
  Fzd5                        0.99                        0.795                                    Egr3       0.88    0.651
  Gucy1a3                     1.13                        0.222                                    Erbb2      1.19    0.521
  Herc3                       1.01                        0.974                                    Erbb3      1.52    0.992
  Hpgd                        1.17                        0.482                                    Esr1       1.21    0.515
  Igf1r                       1.10                        0.564                                    Esr2       0.86    0.606
  Igfbp5                      0.96                        0.753                                    Fos        0.79    0.351
  Irs2                        1.08                        0.733                                    Foxa1      0.32    0.0147[\*](#tfn1){ref-type="table-fn"}
  Jun                         1.08                        0.639                                    Fst        0.97    0.814
  Klk1c2                      2.43                        0.135                                    G6pd       1.11    0.599
  Klk4                        0.95                        0.994                                    Gper1 G    1.06    0.791
  Klkb1                       --                          --                                       Hsp90aa1   0.96    0.731
  Krt8                        1.06                        0.931                                    Igf1       0.86    0.503
  Lama1                       0.90                        0.304                                    Igfbp4     1.51    0.164
  Lifr                        0.90                        0.545                                    Igfbp5     0.98    0.867
  Lrig1                       1.00                        0.975                                    Irs1       1.12    0.629
  Lrrfip2                     1.03                        0.854                                    Junb       0.99    0.790
  Maf                         1.09                        0.692                                    Klkb1      --      --
  Map7d1                      1.01                        0.926                                    L1cam      1.02    0.994
  Mme                         1.00                        0.957                                    Lgals1     1.01    0.883
  Mt2A                        1.15                        0.563                                    Lpl        1.02    0.890
  Myc                         1.23                        0.286                                    Ltbp1      0.89    0.549
  Ncapd3                      1.00                        0.990                                    Maff       0.71    0.473
  Ndrg1                       1.27                        0.127                                    Med1       1.07    0.844
  Nfkb1                       1.05                        0.866                                    Mmp9       2.81    0.357
  Nfkb2                       0.95                        0.816                                    Mta1       1.06    0.678
  Nfkbia                      1.01                        0.773                                    Myc        1.33    0.348
  Nkx3-1                      0.64                        0.102                                    Nab2       1.28    0.685
  Orm1                        --                          --                                       Ncoa2      1.01    0.979
  Pak1ip1                     1.11                        0.0870                                   Ncoa3      1.01    0.969
  Pgc                         --                          --                                       Ncor1      0.81    0.285
  Pias1                       1.10                        0.789                                    Ncor2      0.98    0.888
  Pik3r3                      1.07                        0.794                                    Nov        0.89    0.450
  Pmepa1                      1.14                        0.489                                    Nr0b1      0.84    0.534
  Ppap2a                      0.92                        0.341                                    Nr0b2      --      --
  Rab4a                       0.99                        0.901                                    Nr2f6      1.07    0.787
  Rel                         0.80                        0.131                                    Nr3c1      0.93    0.775
  Rela                        0.97                        0.788                                    Nr5a2      1.33    0.703
  Ripk4                       1.01                        0.888                                    Nrip1      1.21    0.467
  Sgk1                        1.18                        0.369                                    Nrp1       1.39    0.285
  Slc26a2                     1.04                        0.801                                    Pdzk1      1.02    0.987
  Slc45a3                     0.75                        0.509                                    Pelp1      0.95    0.650
  Sms                         0.98                        0.685                                    Pgr        0.71    0.397
  Snai2                       0.79                        0.328                                    Phb2       1.16    0.178
  Sord                        0.97                        0.896                                    Ptch1      1.14    0.725
  Sp1                         1.06                        0.692                                    Ptgs2      1.43    0.504
  Spdef                       1.15                        0.475                                    Rala       1.06    0.587
  Srf                         1.12                        0.564                                    Rara       1.27    0.548
  Steap4                      0.61                        0.302                                    S100a6     0.87    0.539
  Stk39                       0.93                        0.560                                    Safb       1.05    0.831
  Tbc1d8                      1.01                        0.876                                    Snai1      1.15    0.725
  Tiparp                      1.56                        0.988                                    Socs3      1.04    0.885
  Tmprss2                     2.17                        0.0449[\*](#tfn1){ref-type="table-fn"}   Spp1       0.74    0.650
  Tpd52                       1.03                        0.862                                    Tff1       --      --
  Trib1                       1.09                        0.715                                    Tgfa       0.99    0.993
  Tsc22d1                     1.03                        0.370                                    Tgfb3      1.16    0.466
  Tsc22d3                     1.12                        0.587                                    Thbs1      1.05    0.861
  Vapa                        0.99                        0.942                                    Vdr        1.15    0.686
  Vipr1                       0.96                        0.821                                    Vegfa      1.14    0.719
  Wipi1                       1.08                        0.655                                    Wisp2      1.01    0.974
  Zbtb10                      1.10                        0.305                                    Wnt4       0.99    0.997
  Zbtb16                      0.99                        0.889                                    Wnt5a      1.04    0.804
  Zfp189                      1.02                        0.925                                    Xbp1       1.07    0.808

*Fold changes: ratio of the average of BPA group (*n* = 3, two siblings in one sample) to control group (*n* = 3, two siblings in one sample)*.

*--, under detectable*.

*\*P \< 0.05 by Student's t-test*.

An AR signaling target gene, Tmprss2 (NM_130424) was the only gene that was significantly increased in the medial amygdala of neonatal male rats by BPA treatment (fold change 2.17, *P* = 0.0449; Table [1](#T1){ref-type="table"}; Figure [1](#F1){ref-type="fig"}A). An ER signaling target gene, Foxa1 (NM_012742) was the only gene that decreased significantly in the medial amygdala of neonatal male rats by BPA treatment (fold change 0.32, *P* = 0.0147; Table [1](#T1){ref-type="table"}; Figure [1](#F1){ref-type="fig"}B).

![Effect of Bisphenol A (BPA) administration on Tmprss2 and Foxa1 gene expression in the neonatal male rat medial amygdala. **(A)** Effect of BPA administration on the ratio of Tmprss2 gene expression level relative to housekeeping gene (HKG). Each column and the vertical line represent the mean ± SEM (*n* = 3 samples, both sides of medial amygdala of two male siblings in one sample). \**P* \< 0.05, vehicle vs. BPA by Student's *t*-test. **(B)** Effect of BPA administration on the ratio of Foxa1 gene expression level relative to HKG. Each column and the vertical line represent the mean ± SEM (*n* = 3 samples, both sides of medial amygdala of two male siblings in one sample). \**P* \< 0.05, vehicle vs. BPA by Student's *t*-test.](fendo-09-00139-g001){#F1}

Distribution of Tmprss2 and Foxa1 Immunoreactive Cell Bodies in Neonatal Male Rat Brain {#S3-2}
---------------------------------------------------------------------------------------

Location of Tmprss2 and Foxa1-ir cell bodies in P3 male rat brains was analyzed by immunohistochemistry. Abundant Tmprss2-ir cell bodies were found in the olfactory bulb (Figure [2](#F2){ref-type="fig"}A), cerebral cortex (Figure [2](#F2){ref-type="fig"}B), hippocampus (Figure [2](#F2){ref-type="fig"}C), hypothalamus (Figure [2](#F2){ref-type="fig"}D), and amygdala (Figures [2](#F2){ref-type="fig"}E--G). Spindle-like Tmprss2-ir cell bodies of about 10 µm in diameter (Figure [2](#F2){ref-type="fig"}G) were consistently found in all brain areas. The weak blur staining of Tmprss2-ir cell bodies (Figure [2](#F2){ref-type="fig"}G) suggested that Tmprss2 exists in neuronal cellular membrane. Immunohistochemistry without the first antibody served as control (Figure [2](#F2){ref-type="fig"}H).

![Location of Tmprss2-immunoreactive cells in the neonatal male rat brain. **(A)** Tmprss2-immunoreactive (ir) cells in the olfactory bulb of Bisphenol A (BPA) treated P3 rat. AOL, anterior olfactory nucleus, lateral part. AOV, anterior olfactory nucleus, ventral part. **(B)** Tmprss2-ir cells in the secondary motor cortex (M2) of BPA treated P3 rat. **(C)** Tmprss2-ir cells in the hippocampus of BPA treated P3 rat. CA1, field CA1 of the hippocampus; CA2, field CA2 of the hippocampus; CA3, field CA3 of the hippocampus; MoDG, molecular layer of the dentate gyrus. **(D)** Tmprss2-ir cells in the hypothalamus of BPA treated P3 rat. DMH, dorsomedial hypothalamic area; VMH, ventromedial hypothalamic area; 3V, third ventricle. **(E)** Tmprss2-ir cells in the amygdala of vehicle treated P3 rat. MePD, medial amygdaloid nucleus, posterodorsal part; MePV, medial amygdaloid nucleus, posteroventral part. **(F)** Tmprss2-ir cells in the amygdala of BPA treated P3 rat. **(G)** Higher magnification of MePV of BPA treated P3 rat **(F)**. **(H)** Immunohistochemistry without the first antibody showed no immunoreactive cellular structure.](fendo-09-00139-g002){#F2}

Foxa1-ir cell bodies were only found in the peduncular part of lateral hypothalamus (PLH) (Figures [3](#F3){ref-type="fig"}A--C). Three kinds of staining were observed. The first type of staining was even through the cytoplasm and the nucleus, and the cellular diameter was about 10 µm (Figure [3](#F3){ref-type="fig"}C, i). The second type of staining was a weak staining in the cytoplasm and darker staining in the nucleus of about 7 µm in diameter (Figure [3](#F3){ref-type="fig"}C, ii). The third type of staining was an intense staining only in the nucleus (Figure [3](#F3){ref-type="fig"}C, iii). Immunohistochemistry without the first antibody served as control (Figure [3](#F3){ref-type="fig"}D).

![Location of Foxa1-immunoreactive cells in the neonatal male rat brain. **(A)** Foxa1-ir cells in the peduncular part of lateral hypothalamus (PLH) of vehicle treated P3 rat. **(B)** Foxa1-ir cells in the PLH of Bisphenol A treated P3 rat. **(C)** Higher magnification of Foxa1-ir cells in the PLH of vehicle treated P3 rat **(A)**. (i) A cell showing even staining in the cytoplasm and the nucleus. (ii) A cell showing darker staining in the nucleus than the cytoplasm. (iii) A cell showing intense staining only in the nucleus. **(D)** Immunohistochemistry without the first antibody showed no immunoreactive cellular structure.](fendo-09-00139-g003){#F3}

Effect of BPA Administration on the Number of Tmprss2-ir Cells in the Medial Amygdala and Foxa1-ir Cells in the Hypothalamus {#S3-3}
----------------------------------------------------------------------------------------------------------------------------

To investigate the effect of BPA on Tmprss2 and Foxa1 protein expressions, number of Tmprss2-ir cells and Foxa1-ir cells were counted in the medial amygdala and hypothalamus, respectively, of P3 male rats that were daily administered with BPA or vehicle from P1 to P3. The number of Tmprss2-ir cells in the medial amygdala was significantly increased by BPA administration (*P* = 0.032; Figures [2](#F2){ref-type="fig"}E,F and [4](#F4){ref-type="fig"}A). On the other hand, the number of Foxa1-ir cells in the hypothalamus was significantly decreased by BPA administration (*P* = 0.042; Figures [3](#F3){ref-type="fig"}A,B and [4](#F4){ref-type="fig"}B).

![Effect of Bisphenol A (BPA) administration on the number of Tmprss2-ir cells in the medial amygdala and Foxa1-ir cells in the hypothalamus of neonatal male rat. **(A)** Effect of BPA administration on the number of Tmprss2-ir cells in 100 µm grid in the medial amygdala. Each column and the vertical line represent the mean ± SEM. \**P* \< 0.05, vehicle (*n* = 4) vs. BPA (*n* = 5) by Student's *t*-test. **(B)** Effect of BPA administration on the number of Foxa1-ir cells in 100 µm grid in the hypothalamus. Each column and the vertical line represent the mean ± SEM. \**P* \< 0.05, vehicle (*n* = 4) vs. BPA (*n* = 4) by Student's *t*-test.](fendo-09-00139-g004){#F4}

Co-Localization of Tmprss2 andEGFP-GnIH Cells in the Hypothalamus {#S3-4}
-----------------------------------------------------------------

Because Tmprss2 was highly expressed in the hypothalamus of P3 male rat (Figure [2](#F2){ref-type="fig"}D), where GnIH neuronal cell bodies are located, we investigated if some Tmprss2-ir cells are also EGFP-GnIH positive ([@B17]). Abundant EGFP-GnIH cells were observed from the ventral region of ventromedial hypothalamic nucleus (VMH) to the dorsal region of the arcuate nucleus (Arc) as well as along the third ventricle in P3 male rat hypothalamus (Figures [5](#F5){ref-type="fig"}A,C,F,I,L). The diameter of EGFP-GnIH cell bodies in the VMH and Arc was 6--11 µm and had typical GnIH neuronal structure with dendrite or axon-like processes (Figures [5](#F5){ref-type="fig"}A,F,L). 26.5 ± 6.8 (mean ± SD from four different brains) percent of EGFP-GnIH cells in the VMH and Arc were immunoreactive to Tmprss2 antibody (Figures [5](#F5){ref-type="fig"}A--N).

![Tmprss2-immunoreactive EGFP-GnIH neurons in the hypothalamus of neonatal male rat. **(A,B)** EGFP-GnIH neurons **(A)** and Tmprss2-immunoreactive (ir) cells **(B)** in the identical field and focus of hypothalamus. VMH, ventromedial hypothalamic area; Arc, arcuate hypothalamic nucleus; ME, median eminence. **(C--E)** Higher magnification of highlighted area in panel **(A,B)** with identical focus. Panel **(D)** is the merged image of **(C,E)**. Arrows show Tmprss2-ir EGFP-GnIH neurons. \[**(C)** i\] An example of ventricle contacting rod-like EGFP-GnIH cell. \[**(C)** ii\] An example of EGFP-GnIH cell projecting its process to the ventricle. **(F--H)** Higher magnification of highlighted area in panel **(A,B)** with identical focus. Panel **(G)** is the merged image of **(F,H)**. Arrows show Tmprss2-ir EGFP-GnIH neurons. **(I--K)** Higher magnification of highlighted area in panel **(A,B)** with identical focus. Panel **(J)** is the merged image of **(I,K)**. Arrows show Tmprss2-ir EGFP-GnIH neurons. 3V, third ventricle. **(L--N)** Higher magnification of the central area in panel **(F--H)** with identical focus. Arrows show Tmprss2-ir EGFP-GnIH neurons.](fendo-09-00139-g005){#F5}

EGFP-GnIH cells along the third ventricle were different between the dorsal population (Figure [5](#F5){ref-type="fig"}C) and the ventral population in the median eminence (ME) (Figure [5](#F5){ref-type="fig"}I). The dorsal population of EGFP-GnIH cells along the third ventricle had two cell types. The first type had a rod-like structure with a diameter of 4--7 µm and they were directly attached to the ventricle (Figure [5](#F5){ref-type="fig"}C,i). The second type was round shape with a diameter of 4--7 µm situated in the sub-ventricular zone and had a protrusion to the ventricle (Figure [5](#F5){ref-type="fig"}C,ii). The ventral population of EGFP-GnIH cells in the ME had an oval shape with a minor axis of 4--7 µm directly contacted the ventricle and sent long processes to the external zone of the ME (Figure [5](#F5){ref-type="fig"}I). No clear cellular co-localization of Tmprss2 immunoreactivity was observed in EGFP-GnIH cells along the third ventricle either in the dorsal population (Figures [5](#F5){ref-type="fig"}A--E) or ventral population in the ME (Figures [5](#F5){ref-type="fig"}I--K).

Developmental Change in Tmprss2 and Foxa1 Gene Expression in the Amygdala, Hypothalamus, and Telencephalon in the Male Rat Brain {#S3-5}
--------------------------------------------------------------------------------------------------------------------------------

Tmprss2 was equally highly expressed in the amygdala and hypothalamus compared with the telencephalon excluding amygdala and hippocampus in P3 male rat brain (Figure [6](#F6){ref-type="fig"}A). However, Tmprss2 expression in the amygdala and hypothalamus decreased significantly in P35 male rat equivalent to Tmprss2 expression levels in the telencephalon (Figure [6](#F6){ref-type="fig"}A).

![Developmental changes in Tmprss2 and Foxa1 gene expression in the amygdala, hypothalamus, and telencephalon excluding amygdala and hippocampus of male rat. **(A)** The ratio of Tmprss2 gene expression level relative to a housekeeping gene, Rplp1. Each column and the vertical line represent the mean ± SEM (*n* = 5 samples, one sample from one rat). \*\*\*\*\*\**P* \< 0.000001; \*\*\*\*\**P* \< 0.00001, \*\*\**P* \< 0.001 vs. amygdala of P3 male rat (A3) by one-way ANOVA followed by Fisher's protected least significant difference (PLSD) test. ††††*P* \< 0.0001, hypothalamus of P3 male rat (H3) vs. hypothalamus of P35 male rat (H35) by Student's *t*-test. A35, amygdala of P35 male rat; T3, telencephalon excluding amygdala and hippocampus of P3 male rat; T35, telencephalon excluding amygdala and hippocampus of P35 male rat. **(B)** The ratio of Foxa1 gene expression level relative to Rplp1. Each column and the vertical line represent the mean ± SEM (*n* = 5 samples, one sample from one rat). \*\*\**P* \< 0.001; \**P* \< 0.05 vs. A3 by one-way ANOVA followed by Fisher's PLSD test. †*P* \< 0.05, H3 vs. H35 by Student's *t*-test.](fendo-09-00139-g006){#F6}

Foxa1 was expressed significantly higher in the hypothalamus compared with the amygdala of P3 male rats (Figure [6](#F6){ref-type="fig"}B). Although Foxa1 expression in the hypothalamus decreased significantly in P35, it was significantly higher than its expression level in the amygdala of P3 male rats (Figure [6](#F6){ref-type="fig"}B). Foxa1 expression in the telencephalon excluding amygdala and hippocampus was almost under detectable level (Figure [6](#F6){ref-type="fig"}B).

Discussion {#S4}
==========

To understand how perinatal exposure of BPA can modify the neurodevelopmental process and behavior, we first searched for BPA responsive genes from AR and ER signaling target genes by PCR array in the neonatal male rat medial amygdala that were subcutaneously administered with a reference dose of BPA (50 µg/kg BW/day) determined by United States EPA. We found upregulation of *Tmprss2*, an AR signaling target gene, and downregulation of *Foxa1*, an ER signaling target gene. Number of Tmprss2-ir cells in the medial amygdala was also increased and Foxa1-ir cells in the hypothalamus was also decreased in the hypothalamus by BPA administration to neonatal male rats.

*Tmprss2* encodes a multimeric protein that is translated into an N-terminal short cytoplasmic domain, a transmembrane domain, extracellular low-density lipoprotein receptor A domain, a scavenger receptor cysteine-rich domain, and a serine protease domain at the C-terminal ([@B23]). In human tissue, *TMPRSS2* is highly expressed in the small intestine, followed by heart, lung, liver, and small amounts in thymus and prostate. *TMPRSS2* is very highly expressed in the fetal brain but its expression level in the adult brain is minimum ([@B23]). *TMPRSS2* was found to be induced by androgen exposure to prostate cancer cells by microarray containing 1,500 cDNAs ([@B24]). It was shown that TMPRSS2 mediates androgen-induced prostate cancer cell invasion, tumor growth, and metastasis by stimulating a proteolytic cascade ([@B25]).

There is no study investigating the function of Tmprss2 in the brain besides only one study showing its possibility to mediate cancer pain by acting on trigeminal neurons ([@B26]). Significant decrease of *Tmprss2* expression in the amygdala and hypothalamus at 1 month of age suggests that Tmprss2 is related to neurogenesis or neuronal differentiation. In humans, TMPRSS2 is highly expressed in the fetus brain but its expression decreases to undetectable level in the adult brain ([@B23]). Tmprss2-ir cells were consistently distributed in olfactory bulb, cerebral cortex, hippocampus, amygdala, and hypothalamus in 3 days old male rats. We attempted Tmprss2 immunohistochemistry in 1-month-old and adult rat brains but we could not observe positive staining possibly due to its low expression level. The site of Tmprss2 expression corresponds well with that of AR expression in the rat brain ([@B27], [@B28]), suggesting that Tmprss2 expression is regulated by androgen.

In 3-day-old male rat hypothalamus, Tmprss2 was expressed in 26.5% of EGFP-GnIH neurons in the hypothalamus. EGFP-GnIH neurons were clustered from the ventral region of VMH to the dorsal region of Arc at this age, which was similar to fetal rat brain ([@B29]), but unlike GnIH neuronal population in the dorsomedial hypothalamic area in the adult ([@B17], [@B30], [@B31]). Abundant EGFP-GnIH cells were also found along the third ventricle, but clear expression of Tmprss2 was not observed in this region. EGFP-GnIH cells along the third ventricle can be determined as tanicytes from their morphology. Recent lineage-tracing experiments have shown that tanicytes along the third ventricle are hypothalamic stem cells ([@B32]) and postnatally differentiate into neurons and astrocytes in the hypothalamus ([@B33]). These results suggest that Tmprs2 is involved in the construction of neural and glial cellular architecture as a transmembrane protease in neonatal rat brain. Previous study has found that daily subcutaneous injection of a reference dose of BPA (50 µg/kg BW/day) to female Wister rats whose GnRH neurons express EGFP from P0 to P3 decreases numbers of GnIH-ir cell bodies, fiber density, and contacts on GnRH neurons and advances puberty at 1 month of age ([@B34]).

*FOXA1* belongs to the FOXA family of transcriptional regulators (FOXA1, FOXA2, and FOXA3) that play pivotal roles in mammalian development ([@B35]). FOXA proteins serve as pioneering factors in the early sequence of the transcriptional regulatory program. FOXA induces nucleosomal rearrangement that facilitates binding of other transcriptional regulators such as sex steroid hormone nuclear receptors ([@B36]). FOXA1 serves as a pioneering factor that is required for ERα to bind estrogen-response-element after estrogen stimulation ([@B37]). FOXA1 also facilitates AR/chromatin interactions at the regulatory loci near androgen responsive genes ([@B38]). It was shown that BPA promotes epithelial mesenchymal transition of ER-negative breast cancer cells through downregulation of FOXA1 by PI3K/Akt activation ([@B39]). It is possible that BPA also downregulates Foxa1 by activating PI3K/Akt in the brain.

*Foxa1* was highly expressed in the hypothalamus of P3 male rat but significantly decreased in the 1-month-old rat brain, suggesting that Foxa1 is also involved in neuronal differentiation. It was shown that Foxa1 is one of the regulators of neuronal differentiation of midbrain dopamine cells ([@B40]). A recent study showed that ablation of Foxa1 causes impaired development of subthalamic nucleus in mice ([@B41]), a brain region that is next to PLH where intense Foxa1-ir cells were found in P3 male rats in this study. Foxa1 immunoreactivity in the nucleus of the cells in PLH where AR and ER are also expressed ([@B27]) suggests that Foxa1 is involved in transcriptional activities of AR and ER in PLH.

Finally, it was shown that BPA upregulates Tmprss2 and downregulates Foxa1 in the neonatal male rat brain. Location of Tmprss2 and Foxa1-ir cells as well as significant decrease in Tmprss2 and Foxa1 expression in 1-month-old male rat brain suggest that BPA disturbs the neurodevelopmental process and behavior by modifying the expression of Tmprss2 and Foxa1 in the brain.
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